151 related articles for article (PubMed ID: 7085259)
21. Effect of synthetic PAF-acether on human neutrophil function.
Czarnetzki BM; Benveniste J
Agents Actions; 1981 Dec; 11(6-7):549-50. PubMed ID: 7041568
[TBL] [Abstract][Full Text] [Related]
22. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
[TBL] [Abstract][Full Text] [Related]
23. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
Wal F; Joseph D; Touqui L; Vargaftig BB
Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
[TBL] [Abstract][Full Text] [Related]
24. Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons.
Denjean A; Arnoux B; Benveniste J; Lockhart A; Masse R
Agents Actions; 1981 Dec; 11(6-7):567-8. PubMed ID: 7340444
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.
Sánchez-Crespo M; Fernández-Gallardo S; Nieto ML; Baranès J; Braquet P
Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779
[TBL] [Abstract][Full Text] [Related]
27. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
Lefort J; Rotilio D; Vargaftig BB
Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
[TBL] [Abstract][Full Text] [Related]
28. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
29. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
30. Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia.
Prevost MC; Cariven C; Simon MF; Chap H; Douste-Blazy L
Biochem Biophys Res Commun; 1984 Feb; 119(1):58-63. PubMed ID: 6422938
[TBL] [Abstract][Full Text] [Related]
31. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
[TBL] [Abstract][Full Text] [Related]
32. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit.
Honey AC; Lad N; Tuffin DP
Thromb Haemost; 1986 Aug; 56(1):80-5. PubMed ID: 3775692
[TBL] [Abstract][Full Text] [Related]
33. Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets.
Coëffier E; Ninio E; Le Couedic JP; Chignard M
Br J Haematol; 1986 Apr; 62(4):641-51. PubMed ID: 3964558
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung.
Ibbotson GC; Wallace JL
J Lipid Mediat; 1989; 1(5):273-82. PubMed ID: 2519897
[TBL] [Abstract][Full Text] [Related]
35. Effect of platelet activating factor (PAF) on blood flow distribution in the spontaneously hypertensive rat.
Goldstein BM; Gabel RA; Huggins FJ; Cervoni P; Crandall DL
Life Sci; 1984 Sep; 35(13):1373-8. PubMed ID: 6482659
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin.
Morley J; Page CP; Paul W
Br J Pharmacol; 1983 Nov; 80(3):503-9. PubMed ID: 6685552
[TBL] [Abstract][Full Text] [Related]
37. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
[TBL] [Abstract][Full Text] [Related]
38. Intravenous injections of PAF-acether induce platelet aggregation in rats.
Martins MA; Martins PM; Faria Neto HC; Bozza PT; Dias PM; Cordeiro RS; Vargaftig BB
Eur J Pharmacol; 1988 Apr; 149(1-2):89-96. PubMed ID: 3135199
[TBL] [Abstract][Full Text] [Related]
39. A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases?
Benveniste J; Chignard M
Circulation; 1985 Oct; 72(4):713-7. PubMed ID: 3928192
[TBL] [Abstract][Full Text] [Related]
40. CV3988 inhibits in vivo platelet aggregation induced by PAF-acether and collagen.
Robertson DN; Smith GM
Eur J Pharmacol; 1986 Apr; 123(1):91-7. PubMed ID: 3709663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
